Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic effectiveness of parecoxib + hyoscine butylbromide vs urethral lidocaine gel alone during double-J ureteral stent placement
DRKS00040342Phase 4Completed
- Sponsor
- University General Hospital of Alexandroupolis
- Start
- Sep 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of parecoxib, hyoscine butylbromide, lidocaine in hydronephrosis, sponsored by University General Hospital of Alexandroupolis. Started Sep 2025; status: completed.
02
Drugs
parecoxibhyoscine butylbromidelidocaine
03
Conditions
hydronephrosis
Beyond the preview
Go deeper on DRKS00040342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00040342.